RxSight Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	89.08	49.01	22.59	14.68	2.24
Revenue Growth (YoY)	81.77%	116.90%	53.92%	554.98%	-
Cost of Revenue	35.31	27.68	18.08	12.97	4.06
Gross Profit	53.77	21.33	4.52	1.71	-1.82
Selling, General & Admin	74.8	58.67	32.81	15.18	15.2
Research & Development	29.05	25.98	24.5	21.93	29.57
Other Operating Expenses	0	0	0	0.01	-0.52
Operating Expenses	103.85	84.65	57.3	37.12	44.25
Operating Income	-50.09	-63.32	-52.79	-35.41	-46.07
Interest Expense / Income	3.31	4.95	3.68	0.51	0.03
Other Expense / Income	-4.81	-1.52	-7.79	-63.55	-172.34
Pretax Income	-48.59	-66.75	-48.68	27.63	126.24
Income Tax	0.02	0.01	0.01	0.06	0.02
Net Income	-48.61	-66.76	-48.69	27.58	126.22
Preferred Dividends	0	0	0	24.21	100.09
Net Income Common	-48.61	-66.76	-48.69	3.37	26.13
Net Income Growth	-	-	-	-87.12%	-
Shares Outstanding (Basic)	34	28	14	4	-
Shares Outstanding (Diluted)	34	28	14	6	-
Shares Change	24.56%	103.02%	146.28%	-	-
EPS (Basic)	-1.41	-2.41	-3.57	0.91	-
EPS (Diluted)	-1.41	-2.41	-3.57	0.15	-
Free Cash Flow	-46.41	-61.24	-46.65	-37.74	-44.1
Free Cash Flow Per Share	-1.35	-2.21	-3.42	-10.18	-
Gross Margin	60.36%	43.52%	19.99%	11.62%	-81.17%
Operating Margin	-56.23%	-129.21%	-233.64%	-241.26%	-2055.78%
Profit Margin	-54.57%	-136.22%	-215.50%	22.93%	1165.86%
Free Cash Flow Margin	-52.10%	-124.97%	-206.47%	-257.11%	-1967.96%
Effective Tax Rate	-	-	-	0.21%	0.02%
EBITDA	-41.04	-57.78	-41.01	32.15	130.2
EBITDA Margin	-46.07%	-117.90%	-181.52%	219.06%	5809.91%
Depreciation & Amortization	4.24	4.02	3.99	4.01	3.93
EBIT	-45.28	-61.8	-45	28.14	126.27
EBIT Margin	-50.83%	-126.11%	-199.17%	191.73%	5634.54%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).